J
Joseph L. Izzo
Researcher at University at Buffalo
Publications - 232
Citations - 53804
Joseph L. Izzo is an academic researcher from University at Buffalo. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 46, co-authored 229 publications receiving 51755 citations. Previous affiliations of Joseph L. Izzo include Erie County Medical Center & LSU Health Sciences Center New Orleans.
Papers
More filters
Journal ArticleDOI
Hypertension in athletes.
John J. Leddy,Joseph L. Izzo +1 more
TL;DR: The 36th Bethesda Conference classified sports according to their varying physiologic demands and provided specific recommendations for the evaluation, treatment, and sport participation of athletes with HTN.
Journal ArticleDOI
Brachial vs. Central Systolic Pressure and Pulse Wave Transmission Indicators: A Critical Analysis
TL;DR: Based on this overview, there is no compelling scientific or practical reason to replace cuff SBP with any of the newer indicators in the vast majority of clinical situations.
Journal ArticleDOI
Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements.
TL;DR: Olmesartan medoxomil appears to be a safe and effective once‐a‐day treatment for hypertension, indicating 24‐hour effectiveness.
Journal ArticleDOI
Comparative effects of glucagon, hydrocortisone and epinephrine on the protein metabolism of the fasting rat.
TL;DR: In this paper, the metabolic effects of glucagon and hydrocortisone using female rats fasted five days were compared and the results showed that glucagon-treated animals lost more weight and excreted more urinary nitrogen, phosphorus and creatinine than controls.
Journal ArticleDOI
Moderately Obese, Insulin-Resistant Women Exhibit Abnormal Vascular Reactivity to Stress
TL;DR: It is concluded that insulin resistance is associated with an exaggerated blood pressure response to stress; an enhanced vasoconstriction to stress may mediate this response and may be a marker for future hypertension in obese, normotensive, hyperinsulinemic individuals.